Skip to main content
. Author manuscript; available in PMC: 2017 Jul 5.
Published in final edited form as: Vaccine. 2016 Dec 15;35(3):435–442. doi: 10.1016/j.vaccine.2016.11.070

Table 3.

Cost-effectiveness of Haemophilus influenzae type b (Hib)-containing and pneumococcal conjugate vaccine (PCV) compared with no vaccination among children aged <2 years, Yida refugee camp, South Sudan, 2013.

(US$) 1 dose Hib (LL-UL) 2 dose Hib (LL-UL) 1 dose PCV (LL-UL) 2 dose PCV (LL-UL) 1 dose each Hib and PCV (LL-UL) 2 doses each Hib and PCV (LL-UL)
Cost/DALY averted 211 (168–8628) 310 (199–1025) 148 (118–8877) 210 (166–283) 125 (100–6502) 209 (168–266)
Cost/case averted 945 (752–38,685) 1388 (894–4594) 664 (527–39,801) 941 (746,267) 559 (446–29,150) 936 (767–1194)
Cost/death averted 13,038 (10,368–533,590) 19,146 (12,332–63,367) 9161 (7267–548,981) 12,986 (10,292–17,472) 7703 (6157–402,068) 12,909 (10,696–16,475)

LL – lower limit.

UL – upper limit.